Episode 14: Have we reached peak Nitazene?

In this week’s episode, we delve into the rising concern of nitazenes in the recreational drug market. Our discussion centers on a recent study that examines 15 previously uncharacterized nitazene analogues, assessing their potency, μ-opioid receptor activity, and effects in mice. Join us as we break down the study’s findings and discuss their real-world implications for public health and safety.

Hope you enjoy!

Find us on Instagram: @the_tox_lab

Link to the papers we discussed:
https://www.sciencedirect.com/science/article/pii/S1043661824004481?via%3Dihub
https://pmc.ncbi.nlm.nih.gov/articles/PMC10320493/